Coughlin Timothy
Director
Latest Insider Transactions
Showing 10 of 13 transactions (past 365 days)
| 2026-06-10 | 2026-06-09 | VIR Vir Biotechnology, Inc. | Director | Award | 16,000 | $8.51 | $136,160 |
| 2026-06-10 | 2026-06-09 | VIR Vir Biotechnology, Inc. | Director | Award | 8,000 | $0.00 | $0 |
| 2026-06-03 | 2026-06-03 | ADCT Adc Therapeutics Sa | Director | Tax Payment | 12,600 | $3.08 | $38,808 |
| 2026-06-03 | 2026-06-01 | ADCT Adc Therapeutics Sa | Director | Award | 45,000 | $0.00 | $0 |
| 2026-05-21 | 2026-05-19 | TVTX Travere Therapeutics, Inc. | Director | Award | 12,000 | $42.26 | $507,120 |
| 2026-05-21 | 2026-05-19 | TVTX Travere Therapeutics, Inc. | Director | Award | 4,000 | $0.00 | $0 |
| 2026-05-19 | 2026-05-15 | TVTX Travere Therapeutics, Inc. | Director | Sale | 3,250 | $43.49 | $141,343 |
| 2026-05-13 | 2026-05-11 | ATYR Atyr Pharma Inc | Director | Award | 50,000 | $0.95 | $47,500 |
| 2025-11-04 | 2025-10-31 | TVTX Travere Therapeutics, Inc. | Director | Exercise Conversion | 10,000 | $17.44 | $174,400 |
| 2025-11-04 | 2025-10-31 | TVTX Travere Therapeutics, Inc. | Director | Exercise Conversion | 8,000 | $16.33 | $130,640 |
ADCT
Director
Tax Payment
$38.8K
12,600 shares @ $3.08
Filed 2026-06-03Trade 2026-06-03
Adc Therapeutics SaTVTX
Director
Award
$507.1K
12,000 shares @ $42.26
Filed 2026-05-21Trade 2026-05-19
Travere Therapeutics, Inc.TVTX
Director
Sale
$141.3K
3,250 shares @ $43.49
Filed 2026-05-19Trade 2026-05-15
Travere Therapeutics, Inc.TVTX
Director
Exercise Conversion
$174.4K
10,000 shares @ $17.44
Filed 2025-11-04Trade 2025-10-31
Travere Therapeutics, Inc.TVTX
Director
Exercise Conversion
$130.6K
8,000 shares @ $16.33
Filed 2025-11-04Trade 2025-10-31
Travere Therapeutics, Inc.Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.